ACTICOAT◊ Antimicrobial Barrier Dressings
A silver antimicrobial barrier dressing, indicated for use over partial and full-thickness wounds
Act fast on signs and symptoms of infection
ACTICOAT Dressings have a proprietary nanocrystalline structure1 with a large surface area, enabling more bactericidal silver2 to come into contact with wound fluid.
Product feature
Application
Evidence and Case Studies
Related technologies
Medical Education
No Results Message
Customer information
*Compared to Aquacel Ag™, Comfeel™ / Biatain Ag™; n=75.
Recall and Complaints
Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.
Citations
1. Wright et al (1998) 'Efficacy of topical silver against fungal burn wound pathogens', American Journal of Infection Control (1999); 27(4): 344-350
2. West P and Gunning P (2006) Visualisation of silver levels in 2 silver dressings using scanning electron microscopy and energy dispersive X ray microanalysis. Poster at SAWC meeting San Antonio.
3. Wright et al (1998) ‘Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment’, American Journal of Infection Control: 26(6):572-577.
4. Driffield, K; ACTICOAT Flex 3 has antimicrobial activity in 30 minutes, Data on file 0810018, Smith & Nephew.
5. Driffield, K; ACTICOAT Flex 7 has antimicrobial activity in 30 minutes, Data on file 0810014, Smith & Nephew.
6. Gago et al (2008) A comparison of Three Silver - containing Dressings in the Treatment of Infected, Chronic Wounds 20(10): 273-278.
7. Daubney, L: Silver Release Testing of ACTICOAT Flex 3 Dressings. Report reference DS/08/078/R2.
8. Driffield, K; Antimicrobial activity of ACTICOAT Flex 7 against a broad spectrum of wound pathogens, Data on file 0810012, Smith & Nephew.
9. Driffield, K; Antimicrobial activity of ACTICOAT Flex 7 dressings in a seven-day repeat challenge, Data on file 0810013, Smith & Nephew.
10. Driffield, K; Antimicrobial Activity of ACTICOAT Flex 3 against a Broad Spectrum of Wound Pathogens, Data on File reference 0810016.
11. Driffield, K; Antimicrobial activity of ACTICOAT Flex 3 in a three-day repeat challenge, Data on file 0810017, Smith & Nephew
12. Westaim (Sherritt) Report Ref: 93/001 'Broad Spectrum Efficacy'.
13. Westaim Report Ref: # 971030 'The Antimicrobial Activity of Westaim's ACTICOAT Silver Coated Dressing against Clinically Relevant Organsisms over an Extended Period of Time'.
14. Upton, D, Anderson, K. (2010). Pain and stress as contributors to delayed wound healing. Wound Practice & Research: Journal of the Australian Wound Management Association. 18. 114-122.
15. Newton (2010) Reducing MRSA bacteraemias associated with wounds. Wounds uk, Vol 6, No 1
16. Sibbald et al (2001) A screening evaluation of an ionised nanocrystalline silver dressing in chronic wound care. Ostomy Wound management 47 (10), 38-4.
17. Selcuk (2012) Comparison of the antibacterial effect of silver. Burns 38: 1204-1209.
18. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother. 2007 Apr;59(4):587-90.
19. Strohal R, et. al. Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem. J Hosp Infect. 2005 Jul;60(3):226-30.
20. Cuttle L, Naidu S, Mill J, et al. A retrospective cohort study of Acticoat versus Silvazine in a paediatric population. Burns. 2007;33(6):701 - 707.
21. Smith+Nephew 2020.ACTICOAT Classic (ACTICOAT 3) PMCF Activity Summary Report. Internal Report. EO.AWM.PCS105.001.v2.
22. Smith+Nephew 2020.ACTICOAT 7 PMCF Activity Summary Report. Internal Report. EO.AWM.PCS105.002.v2.